Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-01 Sale |
2022-08-03 6:00 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
10,423 | $4.4522 | $46,405 | 800,174 (Direct) |
View |
| 2022-07-18 Sale |
2022-07-20 6:00 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
20,000 | $4.8656 | $97,312 | 810,597 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 6:16 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,100 | $5.0326 | $45,797 | 830,597 (Direct) |
View |
| 2022-06-24 Purchase |
2022-06-27 9:28 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
10,000 | $4.6284 | $46,284 | 38,000 (Indirect) |
View |
| 2022-06-17 Sale |
2022-06-21 7:23 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
9,200 | $4.6778 | $43,036 | 739,697 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 6:01 pm |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
85,000 | $5.1733 | $439,734 | 748,897 (Direct) |
View |
| 2022-02-02 Purchase |
2022-02-04 08:30 am |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
5,000 | $9.74 | $48,700 | 28,000 (Indirect) |
View |
| 2022-01-28 Purchase |
2022-02-01 8:15 pm |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
27,500 | $9.0456 | $248,754 | 841,256 (Indirect Direct) |
View |
| 2021-12-02 Purchase |
2021-12-06 5:31 pm |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
34,326 | $12.82 | $440,059 | 14,186,922 (Indirect) |
View |
| 2021-12-02 Purchase |
2021-12-06 5:11 pm |
Centessa Pharmaceuticals plc | CNTA | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd 10% Owner |
34,326 | $12.82 | $440,059 | 14,186,922 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-01 Option Award |
2022-07-06 6:16 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
750,000 | $0 | 788,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:16 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Financial Officer |
230,000 | $0 | 240,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:16 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development |
100,000 | $0 | 830,597 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:16 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
100,000 | $0 | 941,256 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:15 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Shahidi Javad Chief Medical Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:15 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | CHAO DAVID M Chief Administrative Officer |
230,000 | $0 | 230,500 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:15 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Quality Officer |
140,000 | $0 | 148,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:15 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer |
140,000 | $0 | 140,250 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:15 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel |
160,000 | $0 | 168,500 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:15 pm |
N/A 2032-07-01 |
Centessa Pharmaceuticals plc | CNTA | Hukkelhoven Mathias Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:03 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | GAP (Bermuda) L.P. GENERAL ATLANTIC GENPAR (BERMUDA) L.P. General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp General Atlantic Cooperatief L.P. General Atlantic Partners (Lux) SCSp General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Bermuda) IV L.P. General Atlantic Cooperatief U.A. General Atlantic UM B.V. 10% Owner |
48,000 | $0 | 48,000 (Indirect) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:00 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | Hedley Mary Lynne Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:00 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | GOYAL ARJUN Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:00 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | Stuckley Carol Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:00 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | ZBAR BRETT I W Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:00 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-04 6:00 pm |
N/A 2032-04-01 |
Centessa Pharmaceuticals plc | CNTA | Shahidi Javad Chief Medical Officer |
330,000 | $0 | 330,000 (Direct) |
View |
| 2022-03-21 Other |
2022-03-23 4:56 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer |
52,101 | $0 | 105,202 (Direct) |
View |
| 2022-03-21 Other |
2022-03-23 4:36 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director |
1,839,265 | $0 | 10,605,119 (Indirect) |
View |
| 2022-03-21 Other |
2022-03-23 4:15 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | Medicxi Ventures Management (Jersey) Ltd Medicxi Secondary I LP Medicxi Secondary Co-Invest I LP Medicxi Secondary I GP Ltd. 10% Owner |
1,839,265 | $0 | 10,605,119 (Indirect) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | CHAO DAVID M Chief Administrative Officer |
230,000 | $0 | 230,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | Thorell Marella Chief Accounting Officer |
67,500 | $0 | 67,500 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Quality Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | GRAINGER DAVID J Chief Innovation Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Financial Officer |
230,000 | $0 | 230,000 (Direct) |
View |